GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
Inogen Inc ( (INGN)) has released its Q3 earnings. Here is a breakdown of the information Inogen Inc presented to its investors. Inogen, Inc. is a global medical technology company specializing in ...
The Inogen One G5 Portable Oxygen Concentrator has emerged as a breakthrough solution for individuals requiring supplemental oxygen therapy, combining industry-leading portability with robust ...
Inogen, Inc. INGN is well poised for growth in the coming quarters, courtesy of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the third quarter of 2022 and a ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the ...
Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results